Our CEO, Dr James Garner recently presented an overview of the company as a guest speaker at the 2019 Gold Coast Investment Showcase.
In his presentation, Dr Garner spoke about:
- How brain cancer represents a significant commercial opportunity for GDC-0084, with limited competition
- Kazia’s program of clinical trials around GDC-0084 covering the full range of brain cancers
- How GDC-0084 is the only drug of its kind that is able to cross the blood-brain barrier
- How Kazia is delivering multiple data read-outs from international human trials at world-class cancer hospitals during calendar 2019 - each with significant potential to generate additional investor and partnering interest
Watch the full video presentation here: